Caplin Point Laboratories: September ’22 Results Update
Moneylife Digital Team 29 November 2022
Caplin Point Laboratories (Caplin) continued to report good numbers. In Q2FY22-23, sales rose by 18% y-o-y (year-on-year) to Rs359 crore with sales in Latin America (LatAm) and RoW (rest of the world) and US growing by 10% and 90%, respectively, y-o-y. Caplin Steriles (US business) revenue in H1FY22-23 crossed Rs100 crore, a growth of 63% y-o-y, driven by a healthy mix of products, milestone...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Free Helpline
Legal Credit